What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Type 2 diabetes
Steven E. Kahn focuses on Internal medicine, Endocrinology, Diabetes mellitus, Insulin and Type 2 diabetes.
His research is interdisciplinary, bridging the disciplines of Placebo and Internal medicine.
Endocrinology is frequently linked to Pathogenesis in his study.
Steven E. Kahn combines subjects such as Physical therapy and Hazard ratio with his study of Diabetes mellitus.
His Insulin research integrates issues from Adipose tissue, Hypothalamus and Metabolism.
His research investigates the connection with Type 2 diabetes and areas like Weight loss which intersect with concerns in Overweight and Incidence.
His most cited work include:
- Mechanisms linking obesity to insulin resistance and type 2 diabetes (3314 citations)
- Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. (2411 citations)
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (1600 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Internal medicine, Endocrinology, Diabetes mellitus, Type 2 diabetes and Insulin.
Internal medicine is represented through his Insulin resistance, Impaired glucose tolerance, Obesity, Glucose tolerance test and Body mass index research.
His Insulin resistance research incorporates elements of Waist and Cholesterol.
His Diabetes mellitus study frequently draws connections to other fields, such as Research design.
His Type 2 diabetes research includes elements of Clinical trial, Weight loss, Overweight, Randomized controlled trial and Physical therapy.
His work deals with themes such as Secretion, Carbohydrate metabolism and Arginine, which intersect with Insulin.
He most often published in these fields:
- Internal medicine (89.16%)
- Endocrinology (70.91%)
- Diabetes mellitus (56.08%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (89.16%)
- Diabetes mellitus (56.08%)
- Type 2 diabetes (38.40%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Internal medicine, Diabetes mellitus, Type 2 diabetes, Endocrinology and Insulin.
His Internal medicine research includes elements of Placebo and Prediabetes.
His Diabetes mellitus study which covers Prospective cohort study that intersects with Weight change and Family history.
His Type 2 diabetes research is multidisciplinary, incorporating elements of Metformin, Obesity and Glycemic.
The Endocrinology study combines topics in areas such as Genetically modified mouse and Transgene.
His Insulin research incorporates elements of Adipose tissue and Immune system.
Between 2018 and 2021, his most popular works were:
- Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. (423 citations)
- Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial. (173 citations)
- Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA (86 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Gene
Steven E. Kahn spends much of his time researching Internal medicine, Diabetes mellitus, Type 2 diabetes, Insulin and Insulin resistance.
His Internal medicine study combines topics in areas such as Endocrinology, Nephropathy and Linagliptin.
In most of his Endocrinology studies, his work intersects topics such as Amyloid.
His work on Glycemic is typically connected to Coronavirus as part of general Diabetes mellitus study, connecting several disciplines of science.
Steven E. Kahn has included themes like Metformin, Research design and Insulin sensitivity, β cell function in his Type 2 diabetes study.
Steven E. Kahn combines subjects such as Adipose tissue and Prediabetes with his study of Insulin resistance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
